Health insurance company Humana announced Wednesday that it has reached an agreement to divest nearly its entire ownership position in Gentiva, a hospice and palliative care provider, in a transaction valued at approximately $900 million.
The healthcare giant will transfer its ownership to an investor group, though additional financial details of the arrangement were not revealed.
Humana intends to allocate the sale proceeds toward general corporate operations and indicated the transaction will not impact its projected 2026 financial performance.
The deal is anticipated to finalize during the third quarter of 2026, pending regulatory clearance and standard closing requirements.
Gentiva operates hospice care services and provides support for critically ill patients across more than 430 facilities spanning 35 states.
Humana’s ownership in Gentiva originated from its 2021 acquisition of Kindred at Home, following which the company announced plans to divest non-essential hospice and personal care operations.
In 2022, Humana previously sold a controlling interest in Kindred at Home’s hospice and personal care divisions to private equity firm Clayton, Dubilier & Rice.
